Providence Capital Advisors’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33K Buy
+109
New +$2.05K ﹤0.01% 346
2024
Q4
– Sell
-109
Closed -$4.13K – 326
2024
Q3
$4.13K Hold
109
– – ﹤0.01% 296
2024
Q2
$4.93K Hold
109
– – ﹤0.01% 280
2024
Q1
$5.29K Hold
109
– – ﹤0.01% 268
2023
Q4
$5.84K Hold
109
– – ﹤0.01% 274
2023
Q3
$6.39K Hold
109
– – ﹤0.01% 254
2023
Q2
$6.87K Hold
109
– – ﹤0.01% 236
2023
Q1
$6.86K Hold
109
– – ﹤0.01% 231
2022
Q4
$5.8K Hold
109
– – ﹤0.01% 218
2022
Q3
$6K Hold
109
– – ﹤0.01% 242
2022
Q2
$8K Hold
109
– – ﹤0.01% 216
2022
Q1
$9K Hold
109
– – ﹤0.01% 243
2021
Q4
$11K Hold
109
– – ﹤0.01% 223
2021
Q3
$10K Hold
109
– – ﹤0.01% 226
2021
Q2
$11K Hold
109
– – ﹤0.01% 227
2021
Q1
$11K Hold
109
– – ﹤0.01% 204
2020
Q4
$8K Sell
109
-131
-55% -$10.1K ﹤0.01% 232
2020
Q3
$18K Hold
240
– – 0.01% 138
2020
Q2
$18K Hold
240
– – 0.01% 136
2020
Q1
$14K Hold
240
– – 0.01% 158
2019
Q4
$19K Hold
240
– – 0.01% 155
2019
Q3
$16K Hold
240
– – 0.01% 145
2019
Q2
$19K Hold
240
– – 0.01% 145
2019
Q1
$20K Hold
240
– – 0.01% 153
2018
Q4
$28K Hold
240
– – 0.02% 147
2018
Q3
$29K Hold
240
– – 0.02% 153
2018
Q2
$28K Hold
240
– – 0.02% 144
2018
Q1
$21K Hold
240
– – 0.02% 146
2017
Q4
$18K Buy
+240
New +$16.1K 0.01% 164

Other funds holding USNA

Providence Capital Advisors's USNA Position: Q2 2026 in Review

Providence Capital Advisors opened a new position in Usana Health Sciences (USNA) in Q2 2026: 109 shares worth $2.33K. The stake represents ﹤0.01% of the portfolio and ranks #346 among its holdings. This is a return to the name: Providence Capital Advisors previously reported a position in USNA as recently as Q3 2024.

Providence Capital Advisors first reported a position in USNA in Q4 2017 and has held it in 29 quarters since. The position peaked at $29K in Q3 2018. 137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Providence Capital Advisors held 109 shares of Usana Health Sciences worth $2.33K as of Q2 2026.
  • Usana Health Sciences was a new Providence Capital Advisors position in Q2 2026.
  • Usana Health Sciences made up ﹤0.01% of Providence Capital Advisors's portfolio in Q2 2026, its #346 holding.
  • Providence Capital Advisors first reported a position in Usana Health Sciences in Q4 2017 and has held it in 29 quarters since.
  • Providence Capital Advisors's Usana Health Sciences position peaked at $29K in Q3 2018.
  • 137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Providence Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.